Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

M Schubert, F Bertoglio, S Steinke, PA Heine… - BMC medicine, 2022 - Springer
Background The COVID-19 pandemic is caused by the betacoronavirus SARS-CoV-2. In
November 2021, the Omicron variant was discovered and immediately classified as a …

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA. 1 and BA. 2 by convalescent and vaccine serum and monoclonal antibodies

A Wilhelm, M Widera, K Grikscheit, T Toptan… - …, 2022 - thelancet.com
Summary Background In recent months, Omicron variants of SARS-CoV-2 have become
dominant in many regions of the world, and case numbers with Omicron subvariants BA. 1 …

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma

Y Wang, Y Ma, Y Xu, J Liu, X Li, Y Chen… - Emerging microbes & …, 2022 - Taylor & Francis
Discussion There have been over 8.2 billion doses of SARS-CoV-2 vaccines administrated
in more than 4.3 billion persons around the world [Citation 1]. However, the emerging of the …

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies

X Wang, X Zhao, J Song, J Wu, Y Zhu, M Li… - Emerging microbes & …, 2022 - Taylor & Francis
The massive and rapid transmission of SARS-CoV-2 has led to the emergence of several
viral variants of concern (VOCs), with the most recent one, B. 1.1. 529 (Omicron), which …

Omicron SARS-CoV-2 neutralization from inactivated and ZF2001 vaccines

X Zhao, R Zhang, S Qiao, X Wang… - … England Journal of …, 2022 - Mass Medical Soc
Omicron Neutralization from Vaccines in China In this study, neutralization against the SARS-
CoV-2 omicron subvariants was reduced with both the inactivated and ZF2001 vaccines …

Sub-optimal neutralisation of omicron (B. 1.1. 529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6 …

GR Medigeshi, G Batra, DR Murugesan… - …, 2022 - thelancet.com
Background Rapid spread of the omicron SARS-CoV-2 variant despite extensive
vaccination suggests immune escape. The neutralising ability of different vaccines alone or …

Neutralisation sensitivity of the SARS-CoV-2 omicron (B. 1.1. 529) variant: a cross-sectional study

DJ Sheward, C Kim, RA Ehling, A Pankow… - The Lancet Infectious …, 2022 - thelancet.com
Summary Background The SARS-CoV-2 omicron (B. 1.1. 529) variant, which was first
identified in November, 2021, spread rapidly in many countries, with a spike protein highly …

Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients

CH GeurtsvanKessel, D Geers, KS Schmitz… - Science …, 2022 - science.org
The severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …

SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons

A Rössler, L Riepler, D Bante… - New England Journal …, 2022 - Mass Medical Soc
In Vitro Neutralization of Omicron Variant Serum from vaccinated persons was assayed for
ability to neutralize the omicron variant of SARS-CoV-2. Persons who had received two …

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies

T Tada, H Zhou, BM Dcosta, MI Samanovic… - …, 2022 - thelancet.com
Background SARS-CoV-2 vaccines currently authorized for emergency use have been
highly successful in preventing infection and lessening disease severity. The vaccines …